HPGC Renmintongtai Pharmaceutical Corporation announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 8,005.259 million compared to CNY 8,353.884 million a year ago. Operating income was CNY 220.141 million compared to CNY 363.729 million a year ago. Net income was CNY 145.263 million compared to CNY 267.334 million a year ago. Basic earnings per share from continuing operations was CNY 0.25 compared to CNY 0.461 a year ago.